-
1
Drug deposition in coronary arteries with overlapping drug-eluting stents
Published 2017“…Drug-eluting stents are accepted as mainstream endovascular therapy, yet concerns for their safety may be under-appreciated. …”
Get full text
Get full text
Get full text
Article -
2
Numerical modeling of local pharmacokinetics associated with drug-eluting stent
Published 2009“…To restore distal blood supply and overcome restenosis presented by bare-metal stents, drug-eluting stent (DES) implantation is widely used. However, the long-term efficacy of this mode of treatment is not well-established. …”
Get full text
Thesis -
3
Novel drug-eluting stent to reduce fibrosis-induced ureteral stricture
Published 2015Get full text
Final Year Project (FYP) -
4
Modeling and Analysis of Drug-Eluting Stents With Biodegradable PLGA Coating: Consequences on Intravascular Drug Delivery
Published 2017“…Increasing interests have been raised toward the potential applications of biodegradable poly(lactic-co-glycolic acid) (PLGA) coatings for drug-eluting stents in order to improve the drug delivery and reduce adverse outcomes in stented arteries in patients. …”
Get full text
Get full text
Get full text
Article -
5
Fracture in drug‐eluting stents increases focal intimal hyperplasia in the atherosclerosed rabbit iliac artery
Published 2020“…Objectives: Drug-eluting stent (DES) strut fracture (SF) is associated with higher incidence of In-stent restenosis (ISR)—return of blockage in a diseased artery post stenting—than seen with bare metal stents (BMS). …”
Get full text
Article -
6
The delivery of nitric oxide through liposomes as next generation drug eluting stents and vascular interventions
Published 2022“…Such means of fabrication would hopefully encourage others to pursue the use of NO for future drug eluting stents.…”
Get full text
Thesis-Doctor of Philosophy -
7
A bilayer swellable drug-eluting stent for the treatment of fibrosis-induced ureteral stricture recurrence
Published 2018“…It is hypothesized that a bilayer swellable drug-eluting stent (BSDES) that can co-apt with the urothelium for the localized and sustained delivery of drugs into the diseased section can reduce or eliminate stricture recurrence. …”
Get full text
Thesis -
8
-
9
Characterization and evaluation of a bilayer swellable drug-eluting stent for the treatment of fibrosis-induced ureteral stricture
Published 2017“…The bilayer swellable drug eluting stent is fabricated by first spraycoating an antiproliferative drug, mitomycin C (MMC) encapsulated in a hydrophobic polymer, poly-L-lactide-co-caprolactone (PLC) onto the stent, followed by surface plasma treatment before coating a hydrogel, polyethylene glycol diacrylate (PEGDA) onto the polymer, via photo-crosslinking. …”
Get full text
Final Year Project (FYP) -
10
Comparison of overexpansion capabilities and thrombogenicity at the side branch ostia after implantation of four different drug eluting stents
Published 2021“…This study aimed to evaluate the overexpansion capabilities and thrombogenicity at the SB ostia after implantation of four latest generation drug-eluting stents (DES) in an in-vitro bifurcation model. …”
Get full text
Journal Article -
11
Modelling intravascular delivery from drug-eluting stents with biodurable coating: investigation of anisotropic vascular drug diffusivity and arterial drug distribution
Published 2016“…In-stent restenosis occurs in coronary arteries after implantation of drug-eluting stents with non-uniform restenosis thickness distribution in the artery cross section. …”
Get full text
Get full text
Get full text
Article -
12
Atherosclerotic plaque behind the stent changes after bare-metal and drug-eluting stent implantation in humans: Implications for late stent failure?
Published 2017“…We evaluated the serial changes in PBS following bare-metal (BMS) compared to first-generation drug-eluting stent (DES) implantation and the impact of these changes on in-stent neointimal hyperplasia (NIH). …”
Get full text
Get full text
Get full text
Get full text
Article -
13
A bilayer swellable drug-eluting ureteric stent : localized drug delivery to treat urothelial diseases
Published 2019Subjects: Get full text
Get full text
Journal Article -
14
Impact of flow pulsatility on arterial drug distribution in stent-based therapy
Published 2014“…Drug-eluting stents reside in a dynamic fluid environment where the extent to which drugs are distributed within the arterial wall is critically modulated by the blood flowing through the arterial lumen. …”
Get full text
Get full text
Get full text
Article -
15
-
16
Pathology of Endovascular Stents
Published 2018“…Keywords: Coronary artery disease; Pathology; Bare metal stent; Drug-eluting stent; In-stent restenosis; In-stent thrombosis; Atherosclerosis; Neoatherosclerosis…”
Get full text
Get full text
Get full text
Article -
17
In vitro peptide release from e-polycaprolactone and blends of e-polycaprolactone
Published 2010“…Recent invention of drug-eluting stent (DES) has been successful to prevent ISR but signify a long term thrombosis effect. …”
Get full text
Final Year Project (FYP) -
18
Stent elution rate determines drug deposition and receptor-mediated effects
Published 2016“…Drug eluting stent designs abound and yet the dependence of efficacy on drug dose and elution duration remains unclear. …”
Get full text
Get full text
Article -
19
Evaluation of tissue adhesives for drug eluting balloon using the rotating cylinder
Published 2012“…A stent is also inserted to keep the diseased artery remain open. However, Drug Eluting Stent (DES) is still not a good solution to atherosclerosis as it will cause the onset of late stent restenosis. …”
Get full text
Final Year Project (FYP) -
20
Evaluation of pressure sensitive adhesives for drug eluting balloon
Published 2011“…A stent helps to keep the artery remain open. Although drug eluting stents and drug eluting balloons have been designed, drug eluting stent is not a good solution as restenosis will cause the diseased coronary artery to close after a few years. …”
Get full text
Final Year Project (FYP)